Expo 2017 Agenda


The Chemical Watch Expo brings together expert speakers from regulatory bodies, trade associations and industry to offer delegates a practical series of workshops, spanning three streams: Beginners, Advanced and REACH IT. Pick and choose from the available sessions to create a truly tailored programme to suit your specific requirements.

10:30 Coffee break and plenary session: The ECHA Board of Appeal

Andrew Fasey, Technically Qualified Member of the Board of Appeal European Chemicals Agency, Finland


REACH overview - why, what’s the objective. Understanding the jargon

Istvan Mak, Dossier Submission & PIC Unit, ECHA, Finland


Lessons learned from 2012/2013


Case Study: Only Representatives duties and chemical importation and inspections

Jose V. Cantavella Cabado, Attorney at Law, Head of Legal Dept., ChemSafe SrL, Italy


Chesar in practice

To get the most out of it we recommend you to bring your laptop. Please download Chesar desktop version beforehand from www.chesar.echa.europa.eu/chesar-tool

Dr Roberta Bernasconi, Scientific Officer, Computational Assessment & Dissemination Unit, ECHA, Finland


What is your role? Why it’s important to play it fully and engage

  • Manufacturer, importer, downstream users
  • Formulator, trader, packer, agent?
  • Non-EU, ORs

Frederik Johanson, Partner Sales, REACHLaw, Finland


Changes since 2013

Anne Bergner, SCC-GmbH



REACHING forward:  A look at SUMI, LCID and ESCOM-XML

In this presentation, we will take a look at the future for formulators and how they will need to communicate the Exposure Scenario information to their customers as well as how information may be transmitted through the use of ESCOM-XML

Martina Frenette, Senior Regulations Officer, Sphera Solutions


Substances, know your portfolio - making an inventory and checking how they need to be registered, eg are they intermediates, or exempt

Maria O’Shea, Regulatory and Scientific Consultant, REACH, Chementors, Finland



New provisions in Data sharing

The future for formulators
How they will need to communicate the Exposure Scenario information to their customers
How information may be transmitted through the use of ESCOM-XML

Thomas Delille, Associate, Mayer Brown, Belgium


Automated Read-Across for REACH

This session will provide an update on the collaboration between UL and researchers from John Hopkins University on an automated read-across tool for REACH. We will discuss how this in silico tool will help to minimize animal consumption and will predict toxicity to fill data gaps for the REACH registration process

Anne Bonhoff, UL Environment


Q&A Session


Q&A Session


Challenging CSRs and Higher Tier Assessment

Emma Grange, Senior Consultant, Risk Assessment, Enviresearch

First steps


Getting help. HelpNet, trade associations/consortia, consultants. Tips in selecting a partner. What questions to ask, contracts, schedules, deadlines. Keeping on course. What to do if things go wrong

Dr Simon Oberholzer, Director: Germany, Switzerland & Austria, Lisam  

Testing strategies



Substance Characterisation for REACH

Dr Emma Miller, Scientific and Analytical Services, The REACH Centre, UK


Dossier preparation
Dossier creation
Validation Assistant plug-in

To get the most out of it we recommend you to bring your laptop. Please download IUCLID desktop version beforehand from www.iuclid6.echa.europa.eu/

Sandra Esteves Murras, Dossier Submission & PIC Unit. ECHA, Finland

Tommy Hagg Product Manager - ECHA IT Tools, Computational Assessment & Dissemination Unit, ECHA, Finland



Finding co-registrants, Siefs managing the process

Anna Forsgren, Manager Chemical Advisors, Intertek Semko AB


Testing strategies (2)- for Lead Registration including Data Gap Assessment, Intelligent Testing Strategies and endpoint fulfillment options

Dr Remi Vacherot, Regulatory Toxicologist, The REACH Centre, UK



The ECHA Board of Appeal
How to build a case for an appeal under REACH

ECHA Board of Appeal: introduction (structure and procedure)
Can the decisions of the Board of Appeal be further challenged?

Ruxandra Cana, Partner, Steptoe & Johnson LLP, Belgium &

Darren Abrahams, Partner, Steptoe & Johnson LLP, Belgium


Data needs: Understanding hazard and risk assessment for REACH (dossier is one thing… but know it is the basis for further scrutiny, eg. substance evaluation, authorisation)

Dr Neil Hunt, Senior Regulatory Scientist, The Reach Centre, Chemical Assessment Team, UK


The Role of the CRO on the horizon 2025 - How the CRO can bring proactive approaches regarding tomorrow’s issues

Celia Cavaignac - International Sales Manager

Damien Baudiffier, Ecotoxicologist and RRCo Normative and Regulatory Surveillance Manager, RRCo - Rovaltain Research Company


What will it cost - managing costs and minimising them. SME strategies. Data-sharing - paying for what you need

Claudio Mereu, Partner, Field Fisher Waterhouse, Belgium


Book your ticket

Session 3 - Practical steps

Session 3 - Portfolio management - and other REACH issues

Session 3 


Submitting member dossiers directly in REACH-IT

Terhi Rantala, Scientific Officer, Dossier Submission & PIC Unit, ECHA


Substance identification and how to report it in IUCLID

Dr Laszlo Majoros, Scientific Officer, Substance Identification and Data Sharing Unit, ECHA, Finland


Portfolio management (1)

Organisation and administrative challenges resulting from REACH
How clients have been handling the increased regulatory workload
How implementing digital tools can help

Ankur Saxena, Director of Business & Product Development, Euphor


Current status and Future of  Chemicals Management in Turkey

Dr. Yaprak Yuzak KUCUKVAR -  Manager, RGS Turkey


What next? Dossier completeness check, dossier evaluation (Echa’s strategy), substance evaluation, authorisation, updates

Marko Susnik, Senior Advisor, Austrian Federal Economic Chamber - Wirtschaftskammer Österreich, Austria


Case Study: SVHC management with the DEKRA "Product Chem Risk" tool

Jochen Dettke, Product Manager Chemical regulatory Compliance & Product Sustainability, DEKRA Assurance Services GmbH


REACH’s consequences in the rest of the world:  an overview of how REACH is spreading globally

South Korea

Christine Lepisto, UL


Q&A Session


Q&A Session


Q&A Session

Session 4 - SME case studies

Session 4 - Integrating REACH compliance with global compliance


Cost Reduction in REACH – Alternatives to Testing


SME Case study 

Lars Dobbertin, C.S.B. GmbH, Germany


Dr Michael Cleuvers, Managing Director, Industrial Chemicals & Biocides, Knoell, Germany


The standard endpoints required for REACH registrations are often met by performing the relevant OECD tests in a laboratory. However, there are often other options available that may help to reduce the cost of the registration. These include data waivers, the use of read-across and QSARs. This presentation will provide some background to the available alternatives and their pros and cons. It will also provide some advice about what to look for when reviewing a testing proposal from a CRO

Peter Jenkinson , Managing Director, CEHTRA SAS


Performing due diligence for REACH

EU REACH Focus - from Candidates List (SVHC) to Authorization List (Annex-14) to Restriction List (Annex 17)
Due diligence - data collection, data validation, and data conversation for product level roll-up
Compliance software and tools - quick view on components that are in violation of REACH and generation of product level REACH reports, and easy assessment of compliance status on future SVHC or Annex-14 list

Larry Yen, Green Soft Tech


Optimizing REACH Compliance:  Best practices in proactive chemical substances management

How REACH compliance initiatives can be optimized by taking a more proactive approach to the management of chemical substances
How best to obtain information required to support conformance
Benefits of conducting a feasibility assessment to determine the ease of REACH compliance

Nadeem Butt, 3E company


Read-Across or QSARs? Which one to apply and when?

This talk will primarily focus on providing an overview of the two most commonly applied in silico alternatives, namely Read-Across and QSARs to replace experimental studies (in vivo/in vitro) for regulatory endpoints. Several commonly used Read-Across and QSAR tools will be discussed. For each tool, an overview of its working principle and methodology will be provided and the model performance will be evaluated using multiple case studies. The advantages and disadvantages of the tools and their relevance for regulatory purposes will be discussed. As both of these in silico approaches appear to be similar to the uninitiated, the presenter will also provide some useful tips with some example scenarios to decide whether to apply Read-Across or QSARs for a given situation.

Faizan Sahigara, QSAR Expert, Kreatis SAS


Q&A Session


Worldwide Regulatory Compliance: an overview on GHS implementations in the world

Dr. Ettore Gislon, EHS Regulatory Expert, Selerant srl 

Book your ticket